Spain· ES:53884
DUNA 2,5 mg cápsulas duras
A pinazepam product containing pinazepam, registered in Spain by Meiji Pharma Spain S.A..
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- pinazepam
- Manufacturer
- Meiji Pharma Spain S.A.
- Country
- Spain (ES)
- ATC code
- N05BA14
- ATC class
- Pinazepam
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cima_codigo70065320EUR 3.12
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under N05BA14
Pinazepam, as other registers publish it.
- SpainDUNA 10 mg cápsulas durasMeiji Pharma Spain S.A.
- SpainDUNA 5 mg CAPSULAS DURASMeiji Pharma Spain S.A.
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Italy · Domar
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/77bf09dd-72b6-4b17-a526-3e07205bfc35 GET /v1/drugs/77bf09dd-72b6-4b17-a526-3e07205bfc35?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Medicamento Sujeto A Prescripción Médica. Psicótropos",
"estado": "{\"aut\":223599600000,\"rev\":1749124129000}",
"nregistro": "53884",
"substance": "pinazepam"
}See everything about pinazepam.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.